FDA Inspection
Teva Pharmaceuticals USA, IncTeva Pharmaceuticals USA, Inc – FDA Inspection, Mar 1, 2010
Record Details
This FDA Inspection record concerns Teva Pharmaceuticals USA, Inc, with an inspection on March 1, 2010, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- March 1, 2010
- Product Type
- Drugs
View Company Profile
ID · 884f18be-e214-4216-a0c5-5747a52714aa
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 645466
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
5- 21 CFR 314.81(b)(2)(i)Summary
- 21 CFR 314.81(b)(1)(ii)Failure to meet specifications
- 21 CFR 211.198(a)Adverse Drug Experience
- 21 CFR 211.110(a)Control procedures to monitor and validate performance
- 21 CFR 211.198(a)Complaint Handling Procedure
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Teva Pharmaceuticals USA, Inc
5| Date | Classification | Office | Project area |
|---|---|---|---|
| September 9, 2025 | Not classified | New Jersey District Office | |
| September 29, 2023 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| December 16, 2021 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| December 2, 2010 | VAI | Center for Drug Evaluation and Research | Postmarket Surv. and Epidemiology |
| August 14, 2009 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Teva Pharmaceuticals USA, Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.